Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Iovance
Iovance
FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor
Fierce Pharma
Sun, 02/18/24 - 08:39 pm
Iovance
FDA
Amtagvi
solid tumors
t-cell therapies
cell therapy
Iovance's BLA for Advanced Melanoma Therapeutic Delayed Until Q1 2023
BioSpace
Fri, 11/18/22 - 10:25 am
Iovance
FDA
lifileucel
metastatic melanoma
Iovance (IOVA) Announces Lung Cancer Study Data on TIL Therapy
Yahoo/Zacks.com
Wed, 06/30/21 - 10:52 am
Iovance
LN-145
metastatic non-small cell lung cancer
Iovance Biotherapeutics CEO Fardis departs following FDA setback for lead drug lifileucel
Fierce Biotech
Wed, 05/19/21 - 11:04 pm
Iovance
Pharma CEOs
lifileucel
FDA
FDA gene therapy holdups suggest closer scrutiny by agency
BioPharma Dive
Fri, 11/6/20 - 10:07 am
FDA
gene therapy
Sarepta Therapeutics
Voyager Therapeutics
Iovance
Bluebird Bio
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
R&D
drug development
Eli Lilly
Novartis
Argenx
Bristol-Myers Squibb
Vir Biotechnolgy
Biogen
GSK
Iovance
Roche
Asco 2020 movers – cell therapy companies dominate the risers
EP Vantage
Thu, 06/4/20 - 10:56 am
ASCO 2020
cell therapy
Adaptimmune
Allogene
Iovance
Iovance shares jump on buyout rumors
Fierce Biotech
Wed, 02/26/20 - 10:40 am
immuno-oncology
Iovance
M&A
These 3 Biotech Stocks Could Be Top Stocks in 2020
Motley Fool
Sun, 01/12/20 - 11:19 pm
Biomarin
Iovance
Immunomedics
Emboldened by ASCO data, FDA etches speedy approval path for Iovance's cervical cancer therapy
Endpoints
Tue, 07/2/19 - 10:20 am
FDA
cervical cancer
Iovance
LN-145
June 3 ASCO Quick Takes: ORR of 32% for Celgene's iberdomide in MM; plus Five Prime, Iovance and more
BioCentury
Mon, 06/3/19 - 08:17 pm
ASCO 2019
Celgene
Multiple Myeloma
Five Prime Therapeutics
Iovance
Merck
Moderna Therapeutics
Eli Lilly
ICR
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 05/19/19 - 04:02 pm
Adverum Biotechnologies
ADVM-022
Iovance
LN-145
cervical cancer
MeiraGTx
AAV-RPE65
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Wed, 05/15/19 - 11:52 pm
Iovance
LN-145
cervical cancer
Takeda
TAK-788
non-small cell lung cancer
Amgen
AMG-510
Macrogenics
margetuximab
HER2-positive metastatic breast cancer
Forty Seven
Iovance Continues Path in Developing TIL Treatments for Solid Tumors
BioSpace
Fri, 08/17/18 - 09:39 am
Iovance
solid tumors
lifileucel